Patents by Inventor LINDA M. SMITH RESAR

LINDA M. SMITH RESAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200009177
    Abstract: The presently disclosed subject matter relates to methods of inhibiting cancer stem cells and growth of aggressive and/or poorly differentiated metastatic tumors comprising the cancer stem cells with HMGA1 inhibitors. The presently disclosed subject matter also provides methods of selecting and treating a subject with aggressive and/or poorly differentiated metastatic cancer using HMGA1 inhibitors.
    Type: Application
    Filed: February 4, 2019
    Publication date: January 9, 2020
    Inventors: Linda M. Smith Resar, David Huso, Leslie Cope
  • Patent number: 10213454
    Abstract: The presently disclosed subject matter relates to methods of inhibiting cancer stem cells and growth of aggressive and/or poorly differentiated metastatic tumors comprising the cancer stem cells with HMGA1 inhibitors. The presently disclosed subject matter also provides methods of selecting and treating a subject with aggressive and/or poorly differentiated metastatic cancer using HMGA1 inhibitors.
    Type: Grant
    Filed: January 5, 2017
    Date of Patent: February 26, 2019
    Assignee: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Linda M. Smith Resar, David Huso, Leslie Cope
  • Publication number: 20170202867
    Abstract: The presently disclosed subject matter relates to methods of inhibiting cancer stem cells and growth of aggressive and/or poorly differentiated metastatic tumors comprising the cancer stem cells with HMGA1 inhibitors. The presently disclosed subject matter also provides methods of selecting and treating a subject with aggressive and/or poorly differentiated metastatic cancer using HMGA1 inhibitors.
    Type: Application
    Filed: January 5, 2017
    Publication date: July 20, 2017
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: LINDA M. SMITH RESAR, DAVID HUSO, LESLIE COPE
  • Patent number: 9545417
    Abstract: The presently disclosed subject matter relates to methods of inhibiting cancer stem cells and growth of aggressive and/or poorly differentiated metastatic tumors comprising the cancer stem cells with HMGA1 inhibitors. The presently disclosed subject matter also provides methods of selecting and treating a subject with aggressive and/or poorly differentiated metastatic cancer using HMGA1 inhibitors.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: January 17, 2017
    Assignee: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Linda M. Smith Resar, David Huso, Leslie Cope
  • Publication number: 20150315589
    Abstract: The presently disclosed subject matter relates to methods of inhibiting cancer stem cells and growth of aggressive and/or poorly differentiated metastatic tumors comprising the cancer stem cells with HMGA1 inhibitors. The presently disclosed subject matter also provides methods of selecting and treating a subject with aggressive and/or poorly differentiated metastatic cancer using HMGA1 inhibitors.
    Type: Application
    Filed: May 1, 2015
    Publication date: November 5, 2015
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: LINDA M. SMITH RESAR, DAVID HUSO, LESLIE COPE